Research Frontiers Inc
NASDAQ:REFR
Balance Sheet
Balance Sheet Decomposition
Research Frontiers Inc
Research Frontiers Inc
Balance Sheet
Research Frontiers Inc
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
5
|
5
|
3
|
4
|
3
|
7
|
2
|
4
|
7
|
2
|
8
|
6
|
8
|
6
|
2
|
2
|
3
|
7
|
5
|
0
|
4
|
2
|
2
|
|
| Cash Equivalents |
1
|
5
|
5
|
3
|
4
|
3
|
7
|
2
|
4
|
7
|
2
|
8
|
6
|
8
|
6
|
2
|
2
|
3
|
7
|
5
|
0
|
4
|
2
|
2
|
|
| Short-Term Investments |
7
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
5
|
5
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
8
|
5
|
5
|
3
|
4
|
3
|
7
|
5
|
4
|
7
|
4
|
14
|
12
|
10
|
9
|
5
|
2
|
4
|
7
|
5
|
4
|
5
|
4
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
6
-33%
|
6
-9%
|
3
-50%
|
4
+38%
|
3
-18%
|
8
+136%
|
5
-31%
|
4
-15%
|
8
+74%
|
4
-43%
|
14
+226%
|
12
-17%
|
13
+4%
|
10
-24%
|
5
-45%
|
3
-45%
|
4
+41%
|
8
+103%
|
6
-25%
|
5
-27%
|
5
+18%
|
4
-28%
|
4
+5%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
0
N/A
|
0
+4%
|
0
-24%
|
0
+114%
|
0
-34%
|
0
-16%
|
0
+27%
|
0
+24%
|
0
-24%
|
0
N/A
|
0
N/A
|
0
-23%
|
0
-33%
|
0
+200%
|
0
-2%
|
0
-21%
|
0
-16%
|
1
+210%
|
1
+25%
|
1
-28%
|
1
-13%
|
1
-25%
|
0
-42%
|
1
+331%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
42
|
46
|
51
|
55
|
59
|
62
|
70
|
72
|
76
|
80
|
84
|
87
|
94
|
98
|
102
|
107
|
109
|
112
|
116
|
118
|
120
|
122
|
124
|
126
|
|
| Additional Paid In Capital |
51
|
52
|
56
|
58
|
63
|
65
|
77
|
77
|
81
|
88
|
89
|
102
|
106
|
110
|
111
|
112
|
112
|
115
|
123
|
123
|
123
|
127
|
128
|
128
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
6
-34%
|
5
-9%
|
2
-56%
|
4
+53%
|
3
-18%
|
7
+145%
|
5
-34%
|
4
-14%
|
7
+79%
|
4
-45%
|
14
+245%
|
12
-16%
|
12
+2%
|
9
-25%
|
5
-46%
|
3
-48%
|
3
+21%
|
7
+128%
|
5
-25%
|
4
-29%
|
5
+27%
|
4
-27%
|
3
-26%
|
|
| Total Liabilities & Equity |
9
N/A
|
6
-33%
|
6
-9%
|
3
-50%
|
4
+38%
|
3
-18%
|
8
+136%
|
5
-31%
|
4
-15%
|
8
+74%
|
4
-43%
|
14
+226%
|
12
-17%
|
13
+4%
|
10
-24%
|
5
-45%
|
3
-45%
|
4
+41%
|
8
+103%
|
6
-25%
|
5
-27%
|
5
+18%
|
4
-28%
|
4
+5%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
12
|
12
|
13
|
13
|
14
|
15
|
15
|
15
|
17
|
18
|
19
|
23
|
23
|
24
|
24
|
24
|
24
|
28
|
31
|
32
|
32
|
33
|
34
|
34
|
|